|
CBARA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79767312147305E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8852031047345E-11 |
| Normal-vs-Stage2 |
3.80309999999939E-05 |
| Normal-vs-Stage3 |
7.86050113887882E-11 |
| Normal-vs-Stage4 |
3.77209996571537E-09 |
| Stage1-vs-Stage2 |
9.322400E-01 |
| Stage1-vs-Stage3 |
2.747200E-01 |
| Stage1-vs-Stage4 |
1.495970E-02 |
| Stage2-vs-Stage3 |
4.428600E-01 |
| Stage2-vs-Stage4 |
8.250400E-02 |
| Stage3-vs-Stage4 |
1.664030E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.35179670077446E-11 |
| Normal-vs-AfricanAmerican |
1.30969999956321E-07 |
| Normal-vs-Asian |
1.29039999796632E-08 |
| Caucasian-vs-AfricanAmerican |
3.809700E-04 |
| Caucasian-vs-Asian |
5.374000E-02 |
| AfricanAmerican-vs-Asian |
9.303600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.81350004299941E-09 |
| Normal-vs-Female |
7.28306304154103E-14 |
| Male-vs-Female |
2.619200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04447569984723E-12 |
| Normal-vs-Age(41-60Yrs) |
9.39850419712229E-11 |
| Normal-vs-Age(61-80Yrs) |
1.35029987191615E-10 |
| Normal-vs-Age(81-100Yrs) |
1.189710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.093400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.695200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.145800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.159000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.037000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.565200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.556800E-04 |
| Classical-VS-Follicular |
9.096800E-01 |
| Classical-VS-Other |
8.672800E-01 |
| Classical-VS-Normal |
1.69109171110904E-12 |
| Tall-VS-Follicular |
5.219800E-03 |
| Tall-VS-Other |
7.748000E-02 |
| Tall-VS-Normal |
1.75659486956192E-12 |
| Follicular-VS-Other |
8.708800E-01 |
| Follicular-VS-Normal |
1.30009999987912E-07 |
| Other-VS-Normal |
7.782500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51700005282629E-09 |
| Normal-vs-N1 |
4.66860000003511E-06 |
| N0-vs-N1 |
6.556200E-01 |
|
|
